These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7859047)

  • 1. Particle size: the key to the atherogenic lipoprotein?
    Rajman I; Maxwell S; Cramb R; Kendall M
    QJM; 1994 Dec; 87(12):709-20. PubMed ID: 7859047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein atherogenicity: an overview of current mechanisms.
    Griffin BA
    Proc Nutr Soc; 1999 Feb; 58(1):163-9. PubMed ID: 10343354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans.
    Sartipy P; Camejo G; Svensson L; Hurt-Camejo E
    J Biol Chem; 1999 Sep; 274(36):25913-20. PubMed ID: 10464335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow.
    Packard CJ
    Curr Med Res Opin; 1996; 13(7):379-90. PubMed ID: 8862937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of low density lipoprotein particle composition with atherogenicity.
    Lada AT; Rudel LL
    Curr Opin Lipidol; 2004 Feb; 15(1):19-24. PubMed ID: 15166804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells.
    Weisser B; Locher R; de Graaf J; Vetter W
    Circ Res; 1993 Jul; 73(1):118-24. PubMed ID: 8508523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility.
    Wagner WD; Edwards IJ; St Clair RW; Barakat H
    Atherosclerosis; 1989 Jan; 75(1):49-59. PubMed ID: 2930613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 and small, dense low-density lipoprotein.
    Hurt-Camejo E; Camejo G; Sartipy P
    Curr Opin Lipidol; 2000 Oct; 11(5):465-71. PubMed ID: 11048889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased atherogenicity of low-density lipoprotein in heavy proteinuria.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Nephrol Dial Transplant; 1998 May; 13(5):1183-8. PubMed ID: 9623551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein oxidation and atherosclerosis.
    Young IS; McEneny J
    Biochem Soc Trans; 2001 May; 29(Pt 2):358-62. PubMed ID: 11356183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guinea pig low density lipoproteins: structural and metabolic heterogeneity.
    Luc G; Chapman MJ
    J Lipid Res; 1988 Oct; 29(10):1251-63. PubMed ID: 2466928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
    Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
    Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
    Xu RX; Guo YL; Li XL; Li S; Li JJ
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.